Granulomatosis with polyangiitis secondary prevention: Difference between revisions

Jump to navigation Jump to search
Michael Maddaleni (talk | contribs)
No edit summary
Amandeep Singh (talk | contribs)
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Wegener's granulomatosis}}
{{Wegener's granulomatosis}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}{{ADS}}
==Overview==
==Overview==
There are no established measures for the secondary prevention of granulomatosis with polyangiitis.General follow-ups can be done to check for remission
==Secondary Prevention==  
==Secondary Prevention==  
General well-being and laboratory organ markers are checked on a regular basis to ascertain the patient has remained in remission.
*There are no established measures for the secondary prevention of granulomatosis with polyangiitis.
*General well-being and laboratory organ markers are checked on a regular basis to ascertain the patient has remained in remission.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[fr:Granulomatose de Wegener]]
[[ja:ウェゲナー肉芽腫症]]
[[pt:Granulomatose de Wegener]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Needs content]]
[[Category:Arthritis]]
[[Category:Diseases involving the fasciae]]
[[Category:Rheumatology]]
[[Category:Nephrology]]
[[Category:Pulmonology]]
[[Category:Autoimmune diseases]]

Latest revision as of 23:48, 10 April 2018

Granulomatosis with polyangiitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Granulomatosis with polyangiitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Granulomatosis with polyangiitis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Granulomatosis with polyangiitis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Granulomatosis with polyangiitis secondary prevention

CDC on Granulomatosis with polyangiitis secondary prevention

Granulomatosis with polyangiitis secondary prevention in the news

Blogs on Granulomatosis with polyangiitis secondary prevention

Directions to Hospitals Treating Granulomatosis with polyangiitis

Risk calculators and risk factors for Granulomatosis with polyangiitis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]Amandeep Singh M.D.[3]

Overview

There are no established measures for the secondary prevention of granulomatosis with polyangiitis.General follow-ups can be done to check for remission

Secondary Prevention

  • There are no established measures for the secondary prevention of granulomatosis with polyangiitis.
  • General well-being and laboratory organ markers are checked on a regular basis to ascertain the patient has remained in remission.

References


Template:WikiDoc Sources